Radiology in the immune checkpoint inhibitor era

被引：0

作者：

Park, Benjamin C. ^{[1
,4
]}

Johnson, Douglas B. ^{[2
]}

Lewandowski, Robert J. ^{[3
]}

机构：

[1] Vanderbilt Univ, Med Ctr, Dept Gen Surg, Nashville, TN USA

[2] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA

[3] Northwestern Mem Hosp, Dept Radiol, Chicago, IL 60611 USA

[4] Vanderbilt Univ, Med Ctr, 1161 21st Ave Med Ctr North,D-5203, Nashville, TN 37232 USA

来源：

CLINICAL IMAGING | 2024年 / 107卷

关键词：

Immune checkpoint inhibitors; Interventional oncology; Immune related adverse events; Oncologic imaging;

D O I：

10.1016/j.clinimag.2024.110080

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

The field of oncology has undergone rapid changes following the introduction of immunotherapies and biologics. However, these changes have also created new roles for radiology in both diagnosis and treatment. Our article addresses the evolving role of radiology in the immune checkpoint inhibitor era of oncology. With the progression of new immunotherapies for cancer, imaging paradigms and image guided therapy options have changed. Multidisciplinary oncology teams should be aware of these opportunities for collaboration.

引用

页数：2

共 50 条

[1] Toxicity in the era of immune checkpoint inhibitor therapy
Keam, Synat
Turner, Naimah
Kugeratski, Fernanda G.
Rico, Rene
Colunga-Minutti, Jocelynn
Poojary, Rayansh
Alekseev, Sayan
Patel, Anisha B.
Li, Yuanteng Jeff
Sheshadri, Ajay
Loghin, Monica E.
Woodman, Karin
Aaroe, Ashley E.
Hamidi, Sarah
Iyer, Priyanka Chandrasekhar
Palaskas, Nicolas L.
Wang, Yinghong
Nurieva, Roza
FRONTIERS IN IMMUNOLOGY, 2024, 15
[2] The role of plastic surgery in the immune checkpoint inhibitor era
Park, Benjamin C.
Drolet, Brian C.
Perdikis, Galen
Johnson, Douglas B.
JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY, 2022, 75 (02): : 915 - 916
[3] Association of cytoreductive nephrectomy and survival in the immune checkpoint inhibitor era
Miccio, Joseph
Ma, Sung Jun
Oladeru, Oluwadamilola Temilade
Yang, Daniel X.
Peters, Gabrielle W.
Jethwa, Krishan
Park, Henry S.
Hurwitz, Michael E.
Leapman, Michael
Sprenkle, Preston
Nguyen, Paul
Yu, James
Johung, Kimberly
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
[4] The role of deferred cytoreductive nephrectomy in the era of immune checkpoint inhibitor
Yaegashi, Hiroshi
ANNALS OF ONCOLOGY, 2023, 34 : S1362 - S1362
[5] Survival of Mucosal Melanoma Patients in the Immune Checkpoint Inhibitor Era
Hsu, Charles
Xing, Jessica
Stea, Baldassarre
Dougherty, Shona
Shaheen, Montaser
Christopher, Le
Robbins, Jared
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2021, 44 (10): : S90 - S91
[6] Perioperative therapy in renal cancer in the era of immune checkpoint inhibitor therapy
Kuusk, Teele
Abu-Ghanem, Yasmin
Mumtaz, Faiz
Powles, Thomas
Bex, Axel
CURRENT OPINION IN UROLOGY, 2021, 31 (03) : 262 - 269
[7] End-of-life care in the immune checkpoint inhibitor era.
Buckenheimer, Alyssa
Dothard, Andy Shipe
Russell, Gregory
Grey, Carl
Petty, William J.
Lycan, Thomas
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[8] Immune Checkpoint Inhibitor Use in Sepsis: Monitoring Immune Checkpoint Inhibitor Toxicity
Suresh, Karthik
D'Alessio, Franco
CRITICAL CARE MEDICINE, 2019, 47 (09) : E788 - E788
[9] A closer look at immune checkpoint inhibitor-mediated myocarditis in the era of combined checkpoint blockade and targeted therapies
Guo, Christina
Alexander, Marleise
Dib, Youseph
Lau, Peter
Wheppler, Alison
Au-Yeung, George
Lee, Belinda
Mooney, Don
Joshi, Subodh
Creati, Louise
Sandhu, Shahneen
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 : 168 - 168
[10] Immunotherapy of cancer in the era of checkpoint inhibitor
Mehmi, Inderjit
Hamid, Omid
CLINICAL & EXPERIMENTAL METASTASIS, 2022, 39 (01) : 231 - 237

← 1 2 3 4 5 →